Neuroendocrine Tumors and Second Primary Malignancy - A Relationship with Clinical Impact?

Anticancer Research

Volumn 24, Issue 2 C, 2004, Pages 1049-1051

  Prommegger, Rupert ^a   Ensinger, Christian ^a   Steiner, Philipp ^a   Sauper, Tonja ^a   Profanter, Christoph ^a   Margreiter, Raimund ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Neuroendocrine tumors; Second primary malignancy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; APPENDIX; ARTICLE; BLADDER CARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CAUSE OF DEATH; CLINICAL FEATURE; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUM; JEJUNUM; LIVER CELL CARCINOMA; LUNG; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEUROENDOCRINE TUMOR; PANCREAS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RECTUM; RISK ASSESSMENT; SECOND CANCER; STOMACH; STOMACH CANCER;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; NEUROENDOCRINE TUMORS; RETROSPECTIVE STUDIES;

EID: 2442457957     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lubarsch O: Über den primären Krebs des Ileum nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberkulose. Virchows Arch 3: 280-317, 1888.
2. Oberndorfer S: Karzinoide Tumoren des Dünndarms. Frank Z Pathol 1: 426-9, 1907.
3. Habal N, Sims C and Bilchik AJ: Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 75: 301-6, 2000.
4. Zucker KA, Longo WE, Modlin IM, Bilchik AJ and Adrian TE: Malignant diathesis from jejunal-ileal carcinoids. Am J Gastroenterol 84: 182-6, 1989.
5. Pearson CM and Fitzgerald PJ: Carcinoid tumors - a reemphasis of their malignant nature: review of 140 cases. Cancer 2: 1005, 1944.
6. Gerstle JT, Kauffman GL Jr and Koltun WA: The incidence, management, outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg 180: 427-32, 1995.
7. Tichansky DS, Cagir B, Borrazzo F, Topham A, Palazzo J, Weaver EJ, Lange A and Fry RD: Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum 45: 91-7, 2002.
8. Zyromski NJ, Kendrick ML, Nagorney DM et al: Duodenal carcinoid tumors: How agressive should we be? J Gastrointest Surg 5: 588-93, 2002.
9. Läuffer JM, Zhang T and Modlin IM: Review article: current status of gastrointestinal carcinoids. Aliment Pharmacol Ther 13: 271-87, 1999.
10. Spunt SL, Pratt CB, Rao BN et al: Childhood carcinoid tumors: the St. Jude Children's Research Hospital Experience. J Pediatr Surg 35: 1282-6, 2000.
11. Prommegger R, Obrist P, Ensinger C, Profanter C, Mittermair R and Hager J: Retrospective evaluation of carcinoid tumors of appendix in children. World J Surg 26: 1489-92, 2002.
12. Burgher JC: The probability of the chance occurrence of multiple malignant neoplasms. Am J Cancer 21: 809-924, 1934.
13. Oberg K: Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Ann NY Acad Sci 733: 46-55, 1994.
14. Rehfeld JF: The new biology of gastrointestinal hormones. Physiol Rev 78: 1087-1108, 1998.
15. Reubi JC, Schaer JC and Waser B: Cholecystokinin (CCK)-A and (CCK)-B/gastrin receptors in human tumors. Cancer Res 57: 1377-86, 1997.
16. Schaer JC and Reubi JC: High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents. J Clin Endocrinol Metabol 84: 233-9, 1999.
17. Bold RJ, Ishizuka J, Yao CZ et al: Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptor status. Anticancer Res 18: 4051-56, 1998.
18. Cuttita F, Carney DN, Mulshine J et al: Bombesin-like peptides can function as autocrine growth factors in human small-cell-lung cancers. Nature 316: 823-5, 1985.
19. Chaudhry A, Oberg K, Gobl A et al: Expression of transforming growth factors bl, b2, b3 in neuroendocrine tumors of the digestive system. Anticancer Res 14: 2085-92, 1994.